| 名稱(chēng) | FLT3-ITD D835V/BaF3 |
| 型號(hào) | CBP73097 |
| 報(bào)價(jià) |  |
| 特點(diǎn) | FLT3-ITD [D835V]/BaF3,母細(xì)胞：BaF3，凍存條件：90% FBS+10% DMSO |
產(chǎn)品搜索
產(chǎn)品分類(lèi)
相關(guān)文章
- 羅氏乳腺癌新藥獲英國(guó)NICE批準(zhǔn)用于HER2乳腺癌新輔助治療
- IL6藥物細(xì)胞篩選模型
- 從人結(jié)腸癌細(xì)胞株延伸出早期結(jié)腸癌治療方法
- CD47/PD-(L)1 雙靶點(diǎn)細(xì)胞篩選模型簡(jiǎn)介
- 5T4 (TPBG) 藥靶篩選模型
- 【連載-Toll樣受體系列2】TLR7激動(dòng)劑藥物細(xì)胞篩選模型
- 耳聾基因檢測(cè)標(biāo)準(zhǔn)品
- DKK-1細(xì)胞篩選模型
- 細(xì)胞株有關(guān)細(xì)胞培養(yǎng)污染的控制
- LTβR信號(hào)通路誘導(dǎo)三級(jí)淋巴結(jié)構(gòu)的形成，促進(jìn)趨化因子的表達(dá)
聯(lián)系我們
聯(lián)系人：蔣經(jīng)理
電話(huà)：4008750250
號(hào)碼：
手機(jī)：18066071954
地址：南京市棲霞區(qū)緯地路9號(hào)
Email： zhangxiangwen@cobioer.com
電話(huà)：4008750250
號(hào)碼：
手機(jī)：18066071954
地址：南京市棲霞區(qū)緯地路9號(hào)
Email： zhangxiangwen@cobioer.com
產(chǎn)品展示 / PRODUCTS
藥靶細(xì)胞株 > kinase激酶細(xì)胞株 > CBP73097FLT3-ITD D835V/BaF3
- 詳細(xì)內(nèi)容
| CBP73097 | |
| I. Introduction | |
Cell Line Name： | FLT3-ITD [D835V]/BaF3 |
Host Cell: | Ba/F3 |
| Stability: | 16 passages (in-house test, that not means the cell line will be instable beyond the passages we tested.) |
Application: | Useful for the study of enzyme kinetics, screening inhibitors, and selectivity profiling. |
Freeze Medium: | 90% FBS+10% DMSO |
Complete Culture Medium: | RPMI-1640+10%FBS |
Mycoplasma Status: | Negative |
| II.Background | |
FLT3, receptor-type tyrosine-protein kinase FLT3, activates Akt, Ras, and Erk pathways to regulate differentiation, proliferation, and survival of hematopoietic progenitor cells (PMID: 29316714, PMID: 28538663). Activating mutations of FLT3 are common in hematologic tumors (PMID: 19467916) and the internal tandem duplication (ITD) mutation is commonly observed in acute myeloid leukemia (PMID: 30181385). | |
| III. Representative Data | |
1.FLT3-ITD [D835V]/BaF3 | |
2. Anti-proliferation assay | |
Figure . Anti-proliferation assay of two reference compounds on the FLT3-ITD [D835V]/BaF3 Stable Cell Line. | |
會(huì)員_a.png)